Question 1

What is the catalog number for Human PTGER4 Knockout A549 cell line?

Accepted Answer

The catalog number for Human PTGER4 Knockout A549 cell line is A549KO-17393.

Question 2

What sizes are available for Human PTGER4 Knockout A549 cell line?

Accepted Answer

Human PTGER4 Knockout A549 cell line is available in the following size(s): 1 Vial.

Question 3

Is Human PTGER4 Knockout A549 cell line in stock?

Accepted Answer

Human PTGER4 Knockout A549 cell line is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Human PTGER4 Knockout A549 cell line used for?

Accepted Answer

Engineered clonal A549 cells with PTGER4 gene knockout, sequence confirmed.

Question 5

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 6

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Question 7

Can I return this product if I ordered the wrong one?

Accepted Answer

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.

Human PTGER4 Knockout A549 cell line

Product Specifications

Frequently Asked Questions

Explore Other Products

Cholera Toxin B, CF®660R Conjugate, 100 ug

1,4-Butanediol Diglycidyl Ether

2-Deoxy-2,2-difluoro-4,5-O-isopropylidene-D-threo-pentonic Acid Ethyl Ester

PNA Macrobeads

Ezrin / p81 (CPTC-Ezrin-1), CF488A conjugate, 0.1mg/mL

Anti-ACE2